Global Information
회사소개 | 문의 | 비교리스트

평활근육종 : 세계 임상시험 리뷰

Leiomyosarcoma Global Clinical Trials Review, H1, 2020

리서치사 GlobalData
발행일 2020년 06월 상품 코드 955986
페이지 정보 영문
가격
US $ 2,500 ₩ 2,954,000 PDF (Single User License)
US $ 5,000 ₩ 5,909,000 PDF (Site License)
US $ 7,500 ₩ 8,863,000 PDF (Global License)


평활근육종 : 세계 임상시험 리뷰 Leiomyosarcoma Global Clinical Trials Review, H1, 2020
발행일 : 2020년 06월 페이지 정보 : 영문

세계의 평활근육종 임상시험에 대해 조사 분석했으며, 임상시험 시나리오 개요, 임상시험수, 평균 등록수 등, 세계의 임상시험 상황, 주요 데이터, 주요 기업 등에 대한 체계적인 정보를 제공합니다.

목차

  • 가이던스
  • 조사 범위
  • 임상시험 : 지역별
  • 임상시험수와 평균 등록수 : 국가별
  • 아시아태평양의 임상시험에 기여하고 있는 상위 5개국
  • 유럽의 임상시험에 기여하고 있는 상위 5개국
  • 북미의 임상시험에 기여하고 있는 주요 국가
  • 중동 및 아프리카의 임상시험에 기여하고 있는 주요 국가
  • 중남미의 임상시험에 기여하고 있는 상위 5개국
  • 임상시험 : G7 국가별 - 종양 임상시험에 대한 평활근육종의 비율
  • 임상시험 : G7 국가의 단계별
  • G7 국가의 임상시험 : 임상시험 상황별
  • 임상시험 : E7 국가별 - 종양 임상시험에 대한 평활근육종의 비율
  • 임상시험 : E7 국가의 단계별
  • E7 국가의 임상시험 : 임상시험 상황별
  • 임상시험 : 단계별
  • 진행중인 임상시험 : 단계별
  • 임상시험 : 임상시험 상황별
  • 임상시험 : 평가항목 상황별
  • 일정기간 모집된 피험자수
  • 임상시험 : 스폰서 종류별
  • 유력한 스폰서
  • 평활근육종 치료 임상시험에 참여하고 있는 주요 기업
  • 유력한 의약품
  • 임상시험 프로파일 현황

부록

KSM 20.09.11

List of Tables

List of Tables

  • Leiomyosarcoma Therapeutics, Global, Clinical Trials by Region, 2020*
  • Leiomyosarcoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2020*
  • Leiomyosarcoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2020*
  • Leiomyosarcoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2020*
  • Leiomyosarcoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2020*
  • Leiomyosarcoma Therapeutics Clinical Trials, North America, Top Countries, 2020*
  • Leiomyosarcoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2020*
  • Leiomyosarcoma Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2020*
  • Proportion of Leiomyosarcoma to Oncology Clinical Trials, G7 Countries (%), 2020*
  • Leiomyosarcoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2020*
  • Leiomyosarcoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2020*
  • Proportion of Leiomyosarcoma to Oncology Clinical Trials, E7 Countries (%), 2020*
  • Leiomyosarcoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2020*
  • Leiomyosarcoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2020*
  • Leiomyosarcoma Therapeutics, Global, Clinical Trials by Phase, 2020*
  • Leiomyosarcoma Therapeutics, Global, Clinical Trials In Progress by Phase 2020*
  • Leiomyosarcoma Therapeutics, Global, Clinical Trials by Trial Status, 2020*
  • Leiomyosarcoma Therapeutics Clinical Trials, Global, by End Point Status, 2020*
  • Leiomyosarcoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2015-2019
  • Leiomyosarcoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2020*
  • Leiomyosarcoma Therapeutics Clinical Trials, Global, Key Sponsors, 2020*
  • Leiomyosarcoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2020*
  • Leiomyosarcoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2020*

List of Figures

List of Figures

  • Leiomyosarcoma Therapeutics, Global, Clinical Trials by Region (%), 2020*
  • Leiomyosarcoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2020*
  • Leiomyosarcoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2020*
  • Leiomyosarcoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2020*
  • Leiomyosarcoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2020*
  • Leiomyosarcoma Therapeutics Clinical Trials, North America, Top Countries (%), 2020*
  • Leiomyosarcoma Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2020*
  • Proportion of Leiomyosarcoma to Oncology Clinical Trials, G7 Countries (%), 2020*
  • Leiomyosarcoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2020*
  • Leiomyosarcoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2020*
  • Proportion of Leiomyosarcoma to Oncology Clinical Trials, E7 Countries (%), 2020*
  • Leiomyosarcoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2020*
  • Leiomyosarcoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2020*
  • Leiomyosarcoma Therapeutics, Global, Clinical Trials by Phase (%), 2020*
  • Leiomyosarcoma Therapeutics, Global, Clinical Trials In Progress by Phase, 2020*
  • Leiomyosarcoma Therapeutics, Global, Clinical Trials by Trial Status, 2020*
  • Leiomyosarcoma Therapeutics Clinical Trials, Global, by End Point Status, 2020*
  • Leiomyosarcoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2015-2019
  • Leiomyosarcoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2020*
  • Leiomyosarcoma Therapeutics Clinical Trials, Global, Key Sponsors, 2020*
  • Leiomyosarcoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2020*
  • Leiomyosarcoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2020*
  • GlobalData Methodology

GlobalData's clinical trial report, "Leiomyosarcoma Global Clinical Trials Review, H1, 2020" provides an overview of Leiomyosarcoma Clinical trials scenario. This report provides top line data relating to the clinical trials on Leiomyosarcoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma - Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to Buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

List of Tables

List of Figures

  • Report Guidance
  • GlobalData Clinical Trials Report Coverage
  • Clinical Trials by Region
  • Clinical Trials and Average Enrollment by Country
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
  • Top Five Countries Contributing to Clinical Trials in Europe
  • Top Countries Contributing to Clinical Trials in North America
  • Top Countries Contributing to Clinical Trials in Middle East and Africa
  • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Leiomyosarcoma to Oncology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Leiomyosarcoma to Oncology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
  • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
  • Top Companies Participating in Leiomyosarcoma Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profile Snapshots

Appendix

  • Abbreviations
  • Definitions
  • Research Methodology
  • Secondary Research
  • About GlobalData
  • Contact Us
  • Disclaimer
  • Source
Back to Top
전화 문의
F A Q